Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study
Authors
Keywords
Alzheimers disease, Cognitive impairment, Depression, Cholinesterase inhibitors, Drug therapy, Adverse reactions, Neuropsychological testing, Observational studies
Journal
PLoS One
Volume 9, Issue 2, Pages e89216
Publisher
Public Library of Science (PLoS)
Online
2014-02-20
DOI
10.1371/journal.pone.0089216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuropsychiatric Predictors of Progression from Amnestic-Mild Cognitive Impairment to Alzheimer's Disease: The Role of Depression and Apathy
- (2017) Katie Palmer et al. JOURNAL OF ALZHEIMERS DISEASE
- GOOD or BAD Responder? Behavioural and Neuroanatomical Markers of Clinical Response to Donepezil in Dementia
- (2014) Gabriella Bottini et al. BEHAVIOURAL NEUROLOGY
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Rivastigmine Transdermal Patch
- (2011) Sohita Dhillon DRUGS
- Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer's Disease
- (2011) Hyun Jeong Han et al. Journal of Clinical Neurology
- Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
- (2011) Sube Banerjee et al. LANCET
- Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons
- (2011) Jason A. Bailey et al. PLoS One
- Sertraline for the Treatment of Depression in Alzheimer Disease
- (2010) Paul B. Rosenberg et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease
- (2010) Gianfranco Spalletta et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes
- (2010) Fulvia Di Iulio et al. INTERNATIONAL PSYCHOGERIATRICS
- Switching from Donepezil Tablets to Rivastigmine Transdermal Patch in Alzheimer's Disease
- (2009) Carl H. Sadowsky et al. American Journal of Alzheimers Disease and Other Dementias
- Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients
- (2009) Barbara Vicini Chilovi et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease
- (2009) Francesco Panza et al. DRUGS & AGING
- Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine
- (2009) Joanne Rodda et al. INTERNATIONAL PSYCHOGERIATRICS
- A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer’s disease
- (2009) Jason A. Bailey et al. JOURNAL OF NEUROCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started